Last year alone, Lilly spent $111.8 million advertising Verzenio, according to ad-tracking specialist iSpot.tv, as reported by Fierce Pharma Marketing, an industry newsletter. That made Verzenio the 10th-most advertised drug in the U.S. by spending, up 60% from $70.1 million in 2021.